Action CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Charles River Laboratories International, Inc.

Actions

CRL

US1598641074

Marché Fermé - Nyse
Autres places de cotation
 22:00:02 26/04/2024 		Varia. 5j. Varia. 1 janv.
229 USD +0,54 % Graphique intraday de Charles River Laboratories International, Inc. -1,52 % -3,12 %
25/04 FibroBiologics, Inc. prévoit de collaborer avec Charles River Laboratories pour fabriquer des sphéroïdes à base de fibroblastes CI
24/04 Charles River Laboratories dépose un supplément à la circulaire de sollicitation de procurations définitive auprès de la Securities and Exchange Commission CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International : 2023 Corporate Citizenship Report
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc Receives a Shareholder Proposal from People for the Ethical Treatment of Animals
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CRL
  4. Actualités Charles River Laboratories International, Inc.
  5. Autres langues